Ad:

Latest clinical trial in amyotrophic lateral sclerosis (ALS)

CNS disorders
09-09-2014,
Michal Manka

You can read this text in 1 min.

Latest clinical trial in amyotrophic lateral sclerosis (ALS)

Pantherstock

Research in the laboratory

A Phase II clinical trial of the therapeutic substance Neuralstem (NIS-566/ALS) has been announced at Emory University in Atlanta.

Ad:
Want to keep up to date? Follow us on G o o g l e News
Related
Topics
Als Amyotrophic lateral sclerosis Clinical-research Motor neurons
See also in
español français deutsch polskim

The content and materials contained in this site are for educational and informational purposes. The publisher and editors of the site are not responsible for the effects of their application. It is imperative that you consult your doctor before applying the advice and tips contained in the site.